Trials / Recruiting
RecruitingNCT03692884
Chongqing Diabetes Registry Study
Chongqing Diabetes and Its Chronic Complications Registry Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Chongqing Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
To investigate the risk factors and biomarkers of the microvascular disease，macrovascular disease and neuropathy in patients with diabetes.
Detailed description
This study is a prospective cohort study. About 5000 patients with diabetes from the Chongqing Diabetes Centre,Chongqing,China, will be enrolled for long-term follow-up.Information on socio-demographic parameters, medical history, current drug use,lifestyle factors, anthropometric measurements, metabolic control indicators and diabetes complications examination will be documented. Blood and urine samples will be collected. This study aimed to assess risk factors and biomarkers of occurrence and development of diabetic microvascular disease,macrovascular disease and neuropathy in patients with diabetes.
Conditions
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2030-07-01
- Completion
- 2030-07-01
- First posted
- 2018-10-02
- Last updated
- 2023-09-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03692884. Inclusion in this directory is not an endorsement.